U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ENOBLITUZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
enoblituzumab [INN]
Preferred Name English
MGA-271
Code English
Enoblituzumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(ANTIGEN B7-H3) (HUMAN-MUS MUSCULUS MONOCLONAL MGA271 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MGA271 K-CHAIN, DIMER
Common Name English
ENOBLITUZUMAB [USAN]
Common Name English
MGA271
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
Code System Code Type Description
SMS_ID
100000177952
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
DRUG BANK
DB15017
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
USAN
BC-80
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109638
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
CAS
1353485-38-7
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
NCI_THESAURUS
C97510
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
INN
10165
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
WIKIPEDIA
Enoblituzumab
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
ChEMBL
CHEMBL3545373
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
FDA UNII
M6030H73N9
Created by admin on Mon Mar 31 22:48:19 GMT 2025 , Edited by admin on Mon Mar 31 22:48:19 GMT 2025
PRIMARY
ACTIVE MOIETY
ENOBLITUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966